Medical Search

Medical News from Wall Street Journal

FDA Appears to Back HIV Drug

May 8, 2012, 9:09 am by Wall Street Journal

The FDA appeared to support the use of a Gilead HIV drug in healthy people to help prevent them from contracting the virus that causes AIDS.


Featured Medical Stories

Fitbit Blaze

Have you seen the latest Fitbit?

Fitbit has come a long way and continues to be the top fitness tracker. And now, it is seen as an eye catching fashion accessory and a fitness bling statement. Fitbit's new Blaze is a tracking device and a fashion statement. It has beautiful design and is packed full of features. Check out this wrist candy and all the cool features it has to offer here >> See the HOTTEST new Fitbit!

See the HOT Fitbit Blaze Now Compare All Fitbit Products Google Fitbit
Matcha Green Tea Super Food Antioxidants

Matcha Green Tea King of Superfoods

Matcha Green Tea is the latest superfood that celebs and regular folk are finding give them supercharged antioxidant purification with a non-jittery sense of focus. Most matcha available to buy is in very small sizes and is not high enough quality. It is important that you buy high quality matcha. We've found bulk high quality 100% natural matcha green tea imported from Japan. Learn more here: Japanese Matcha Green Tea in bulk here on Amazon

High Quality Matcha Find Matcha on Amazon Google Matcha Green Tea

More medical news from Wall Street Journal

FDA Wants Zika Testing for All Donated Blood
Wall Street Journal : August 26, 2016, 5:05 am
The Food and Drug Administration is calling for Zika testing of all donated blood and blood products nationwide as a preventive measure to help stem the spread of the virus.

Avian Flu Found in Wild Duck in Alaska
Wall Street Journal : August 26, 2016, 2:25 am
A highly lethal form of avian flu was detected in a wild mallard duck in Alaska, reigniting fears of a return of the virus that hasn't been spotted in the U.S. for more than a year.

Mylan's EpiPen Price Increases Highlight Its Grip on the Market
Wall Street Journal : August 25, 2016, 4:36 am
The ability of Mylan to raise EpiPen’s list price by nearly 550% over the past eight years underscores the pricing power drug companies enjoy for iconic brands facing little competition.

Burden of Health-Care Costs Moves to the Middle Class
Wall Street Journal : August 25, 2016, 4:36 am
Rising out-of-pocket health care costs, combined with slow economic growth and years of tepid wage growth, pose risks for an economy in which consumer spending accounts for more than two-thirds of overall output.

Mylan Faces Scrutiny Over EpiPen Price Increases
Wall Street Journal : August 24, 2016, 7:58 am
Mylan became the latest pharmaceutical company to face outrage about higher drug costs after the company’s substantial price increases for the EpiPen emergency allergy treatment.